Anthony S. Fauci, MD to Deliver Keynote Address During the 2020 American Urological Association Virtual Experience

June 11, 2020

Anthony S. Fauci, MD will be the Association’s keynote speaker during American Urological Association (AUA) Live, a component of the Association’s 2020 Virtual Experience. Dr. Fauci’s keynote address will take place on Saturday, June 27, at 11:30 a.m. (ET).

Anthony S. Fauci, MD is one of the most visible faces of the U.S. response to the coronavirus pandemic, the National Institute of Allergy and Infectious Diseases (NIAID) director who will provide an update on COVID-19, as well as the research community’s response to the pandemic.

“We are very excited to welcome Dr. Fauci as part of the 2020 AUA Virtual Experience, and his presentation could not be more timely,” said John D. Denstedt, MD, Secretary of the AUA Board of Directors. “He will set the tone for the important work being done every day to manage COVID-19 and reflect on the impact it has had on the urology community, as well as the broader medical community.”

Dr. Fauci is one of the most prominent members of the White House Coronavirus Task Force and has advised six U.S. Presidents on many domestic and global health issues, including HIV/AIDS for more than three decades. He is the recipient of numerous prestigious awards, including the Presidential Medal of Freedom (the highest honor given to a civilian by the President of the United States).

“To date, there have been more than 7.1 million reported cases of COVID-19 around the world and about 410,000 confirmed deaths,” said Denstedt. “Hearing more from Dr. Fauci about a collaborative approach to the clinical testing, scaling capacity and distribution of candidate vaccines to prevent COVID-19 is important to our members and to promoting the highest standards of clinical care.”

Dr. Fauci has served as the director of the NIAID since 1984 and oversees an extensive research portfolio of basic and applied research to prevent, diagnose, and treat established infectious diseases such as tuberculosis, malaria, respiratory infections, as well as emerging diseases such as Ebola and Zika. Additionally, he supports research on transplantation and immune-related illnesses, including autoimmune disorders, asthma and allergies.

The AUA continues to be a leader in developing innovative, evidence-based quality education for urologists and urologic health care professionals worldwide. Through the AUA Virtual Experience—and other year-round educational offerings—the AUA sets the highest standards for urologic education and provides unparalleled access to groundbreaking research, new guidelines and the latest advances in urologic medicine. Register here.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The Evolut ™ FX+ TAVR system leverages market-leading valve performance with addition of larger windows to facilitate coronary access
The study was an analysis of AstraZeneca’s Phase 2 52-Week clinical trial of tralokinumab in patients with Idiopathic Pulmonary Fibrosis (IPF). The patient data from the trial was processed with Brainomix’s e-Lung tool. The tool is uniquely powered by the weighted reticulovascular score (WRVS), a novel biomarker that incorporates reticular opacities and vascular structures of the lung.
“Since the algorithm for matching patients with donors is changing across for all organs, this was a prime time to better understand whether transplant team decisions to accept a donated organ varied by patient race and gender,” she said. “We wanted to understand how the process of receiving a transplant after listing varied by race and gender, and the combination of the two, so that steps can be taken to make that process more equitable," said Khadijah Breathett, MD.
The Mount Sinai study found that primary care physicians’ approach reflects a dearth of evidence-based guidance for lung cancer screening shared decision-making in patients with complex comorbidities
This is the first ever transplantation of a genetically engineered porcine kidney into a living human recipient.

By using this website you agree to accept Medical Device News Magazine Privacy Policy

Exit mobile version